NHS: The High Yield Is Not A Reason To Own This Fund (Rating Downgrade)

Neuberger High Yield Strategies Fund (NHS) offers a 19.15% distribution yield but is not generating sufficient income to cover the payout, creating a risk of continued NAV erosion. The fund is concentrated almost entirely in fixed-rate high-yield bonds, leaving it exposed to rising rates and inflation. Although NHS trades at an 11.13% discount to NAV, it has underperformed junk-bond benchmarks and its discount does not offset the distribution-sustainability risk.

Analysis

NHS’s headline yield is economically closer to a return-of-capital mechanism than a credit-income stream if net investment income remains below the managed distribution. The relevant risk is not simply a lower payout: persistent overdistribution compounds NAV erosion, reduces future earning assets, and can widen the discount as income-focused holders reassess sustainability. An 11% discount is therefore not necessarily a margin of safety; it can be insufficient compensation for a structurally declining NAV and an eventual distribution reset.

The portfolio’s fixed-rate bias leaves NHS exposed to two distinct pressures over the next 1-3 months: duration-driven NAV weakness if Treasury yields reprice higher, and spread widening if inflation or growth concerns impair below-investment-grade credit. More importantly, credit spreads can remain benign while the fund still disappoints because its core problem is carry relative to the payout rate. A lower-rate environment would help NAV, but it would not alone cure an unsustainably high distribution unless portfolio income rises or the payout is reduced.

The better expression is avoidance rather than an outright short: closed-end fund borrow can be scarce and the distribution creates material negative carry for shorts. For investors requiring high yield, favor vehicles where distribution coverage and floating-rate exposure reduce NAV-destructive risk. A catalyst path is the next shareholder report/NII disclosure and any distribution-policy update; evidence of stable or improving coverage would falsify the bear case, while another sequential NAV decline after distributions would confirm it.

Key Decisions for Investors

• Avoid initiating NHS despite the discount; require at least two reporting periods of distribution coverage near 100% and stabilization in NAV per share before reassessing.
• For credit-income exposure over the next 3-12 months, rotate toward floating-rate senior-loan proxies such as BKLN or actively managed loan CEFs only after confirming leverage, discount, and distribution coverage; this reduces duration sensitivity relative to fixed-rate high yield.
• Use HYG or JNK puts as a tactical hedge if inflation data or Treasury yields reaccelerate; a 1-3 month hedge is cleaner than shorting NHS because it avoids fund-specific borrow and distribution carry.
• Set an alert around NHS’s next semiannual/annual report: a further decline in net investment income coverage, a distribution cut, or discount widening beyond roughly 15% would validate continued avoidance rather than create an automatic value entry.